Skip to main content
. 2020 May 5;5(19):10878–10890. doi: 10.1021/acsomega.0c00529

Figure 1.

Figure 1

Ginsenoside Rg1 inhibits insulin resistance in animal models of NAFLD. (A) The morphology of liver tissues in the control group or model group was detected by HE staining and oil red O staining. (B) Ginsenoside Rg1 inhibits insulin resistance after ginsenoside Rg1 treatment for 4 or 8 weeks. The values shown are the mean ± standard error of the mean (SEM) of the data from three independent experiments. #Significant compared with the control group alone, P < 0.05; *significant compared with the model group alone, P < 0.05. (C) The molecular formula of ginsenoside Rg1.